Climate Change Data Portal
DOI | 10.1073/pnas.2022142118 |
Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets | |
Wang M.-Y.; Dean E.D.; Quittner-Strom E.; Zhu Y.; Chowdhury K.H.; Zhang Z.; Zhao S.; Li N.; Ye R.; Lee Y.; Zhang Y.; Chen S.; Yu X.; Leonard D.C.; Poffenberger G.; Deylen A.V.; McCorkle S.K.; Schlegel A.; Sloop K.W.; Efanov A.M.; Gimeno R.E.; Scherer P.E.; Powers A.C.; Unger R.H.; Holland W.L. | |
发表日期 | 2021 |
ISSN | 00278424 |
卷号 | 118期号:9 |
英文摘要 | We evaluated the potential for a monoclonal antibody antagonist of the glucagon receptor (Ab-4) to maintain glucose homeostasis in type 1 diabetic rodents. We noted durable and sustained improvements in glycemia which persist long after treatment withdrawal. Ab-4 promoted β-cell survival and enhanced the recovery of insulin+ islet mass with concomitant increases in circulating insulin and C peptide. In PANIC-ATTAC mice, an inducible model of β-cell apoptosis which allows for robust assessment of β-cell regeneration following caspase-8-induced diabetes, Ab-4 drove a 6.7-fold increase in β-cell mass. Lineage tracing suggests that this restoration of functional insulin-producing cells was at least partially driven by α-cell-to-β-cell conversion. Following hyperglycemic onset in nonobese diabetic (NOD) mice, Ab-4 treatment promoted improvements in C-peptide levels and insulin+ islet mass was dramatically increased. Lastly, diabetic mice receiving human islet xenografts showed stable improvements in glycemic control and increased human insulin secretion. © 2021 National Academy of Sciences. All rights reserved. |
英文关键词 | Diabetes; Glucagon; Insulin; Islet; Regeneration |
语种 | 英语 |
来源期刊 | Proceedings of the National Academy of Sciences of the United States of America |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/180469 |
作者单位 | Touchstone Diabetes Center, Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX 75390-8549, United States; Medical Service, Veterans Administration North Texas Health Care System, Dallas, TX 75216, United States; Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University, Medical Center, Nashville, TN 37232, United States; Department of Molecular Physiology and Biophysics, Vanderbilt University, School of Medicine, Nashville, TN 37232, United States; Department of Nutrition and Integrative Physiology, University of Utah, College of Health, Salt Lake City, UT 84112, United States; Diabetes and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, United States; Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States; Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, School of Medicine... |
推荐引用方式 GB/T 7714 | Wang M.-Y.,Dean E.D.,Quittner-Strom E.,et al. Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets[J],2021,118(9). |
APA | Wang M.-Y..,Dean E.D..,Quittner-Strom E..,Zhu Y..,Chowdhury K.H..,...&Holland W.L..(2021).Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets.Proceedings of the National Academy of Sciences of the United States of America,118(9). |
MLA | Wang M.-Y.,et al."Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets".Proceedings of the National Academy of Sciences of the United States of America 118.9(2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。